Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study.
- DOI
- 10.1038/s41598-026-52212-4
- Published
- 2026 Jun 12
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-026-52212-4,
title = {Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study.},
author = {Song JR and Jeon J and Baek SC and Sharma A and Sagong M and Lee CS and Woo SJ and International Retina Biosimilar Study Group (Inter BIOS Group)},
year = {2026},
journal = {Scientific reports},
doi = {10.1038/s41598-026-52212-4},
url = {https://doi.org/10.1038/s41598-026-52212-4}
}RIS
TY - JOUR TI - Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study. AU - Song JR AU - Jeon J AU - Baek SC AU - Sharma A AU - Sagong M AU - Lee CS AU - Woo SJ AU - International Retina Biosimilar Study Group (Inter BIOS Group) PY - 2026 JO - Scientific reports DO - 10.1038/s41598-026-52212-4 UR - https://doi.org/10.1038/s41598-026-52212-4 ER -
APA
JR, S., J, J., SC, B., A, S., M, S., CS, L., SJ, W., & Group), I. R. B. S. G. (. B. (2026). Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study.. Scientific reports. https://doi.org/10.1038/s41598-026-52212-4
Source records
- pubmed · retrieved 2026-09-26T00:51:30.070Z